Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Ramucirumab; Drug: Pembrolizumab; Other: EORTC QLQ-30; Other: FACT H&N; Procedure: Peripheral blood
Sponsors: Washington University School of Medicine; Eli Lilly and Company
Not yet recruiting
https://ift.tt/2NuYeVd
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου